Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
aldesleukin
×
Thoracic
×
Clear all
Filters
3
NCT02876510
2025-02-04
ACTolog
Immatics US, Inc.
Phase 1
Completed
38 enrolled